Summary & Overview
Abortion without D&C: Inpatient Reimbursement Overview
DRG 779 addresses inpatient admissions for abortion without dilation and curettage, encompassing medical or minor surgical pregnancy termination procedures managed in the hospital. This grouping matters for inpatient reimbursement because it standardizes payment based on expected resource use for these cases under Medicare policy.
DRG 779 Overview
DRG 779 covers inpatient admissions for abortion procedures performed without dilation and curettage, typically including medical or minor surgical termination of pregnancy when managed in an inpatient setting. This Diagnosis-Related Group groups cases with similar clinical resource use and is used by Centers for Medicare & Medicaid Services and payers to determine standardized payment for the inpatient stay. Understanding this DRG is important for accurate coding and billing because it affects case classification and reimbursement. It applies when the principal procedure and clinical circumstances meet the grouping criteria for an inpatient claim.
Clinical Trials
- Trials comparing medical versus expectant management for first-trimester abortion without surgical evacuation, focusing on efficacy, rates of complete abortion, and short-term complications. These studies enroll patients seeking non-surgical termination and evaluate different medication regimens, timing of follow-up, and criteria for identifying treatment failure. Results inform providers about safe outpatient protocols and help payers predict resource use and avoid unnecessary inpatient procedures.
- Comparative effectiveness studies of pain control and antiemetic strategies during nonsurgical abortion care, often randomized or pragmatic in design, assessing analgesic regimens, routes of administration, and patient-reported pain and satisfaction. These trials include diverse outpatient populations, including varying gestational ages within the indication for non-D&C abortion, and examine immediate care needs and recovery profiles. Findings guide inpatient and ED clinicians on best practices to reduce procedure-related admissions, optimize symptom management, and control short-term costs.
- Post-discharge outcomes and health services research tracking unplanned healthcare utilization, complications, and contraceptive uptake after abortion without D&C, using cohort designs or registry data to monitor 30–90 day outcomes. Populations studied include patients discharged after medical management or expectant care, with attention to social determinants, access to follow-up, and rates of subsequent procedures or hospital readmission. This research is relevant for payers and health systems to design follow-up pathways, reduce avoidable readmissions, and measure long-term cost-effectiveness of outpatient abortion services.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.